Blok B, Van Kerrebroeck P, de Wachter S, et al. - Since the Axonics System is the first rechargeable sacral neuromodulation (SNM) device and is qualified to last a minimum of 15 years in the body. The study was undertaken to investigate the safety and efficacy of this rechargeable SNM system. A total of 51 subjectssum of 51 individuals were implanted with the Axonics System in a single nonstaged technique. It was noted that 90% of the Test Responders continued to respond to the therapy based on voiding diary criteria at 2 years. At 2 years, clinically meaningful improvements were found after using the Axonics System® in overactive bladder (OAB) individuals. No serious device‐related AEs were noted. Continued satisfaction was reported in the individuals with the therapy.